Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Efficacy and Safety of HB-1 for Panic Disorder
- Conditions
- Panic DisorderMental Illness
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 240
- Registration Number
- NCT06483789
- Locations
- π¦πΊ
Paratus Clinical Research Canberra, Canberra, Australian Capital Territory, Australia
π¦πΊParatus Clinical Research Western Sydney, Blacktown, New South Wales, Australia
π¦πΊParatus Clinical Research Central Coast, Kanwal, New South Wales, Australia
Safety and Efficacy of HB-1 for Panic Disorder
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 86
- Registration Number
- NCT05071430
- Locations
- πΊπΈ
Collaborative Neuroscience Research, Garden Grove, California, United States
πΊπΈLumos Psychiatric Services, San Jose, California, United States
πΊπΈInstitute of Living, Hartford, Connecticut, United States